Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts
NCT02377999
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Anogenital Warts
Interventions
DRUG:
Picato
Sponsor
LEO Pharma